2-FDCK

2-FDCK, also known as 2-Fluorodeschloroketamine, is a synthetic drug similar to ketamine. It belongs to the arylcyclohexylamine class, which includes substances like PCP and ketamine. First appearing around 2013, 2-FDCK has gained attention as a new psychoactive substance (NPS).

How Does 2-FDCK Work?

2-FDCK acts as a dissociative anesthetic, affecting the brain by blocking certain receptors, leading to altered perceptions and sensations. Users may experience detachment from reality, hallucinations, and euphoria. These effects are similar to those of ketamine but can vary in intensity and duration.

Potential Risks and Side Effects

The use of it carries several risks:

• Neurological Effects: Impaired consciousness, agitation, abnormal behavior, and, in severe cases, loss of consciousness or convulsions.

• Cardiovascular Issues: Increased heart rate (tachycardia) and high blood pressure (hypertension).

• Addiction Potential: Studies suggest that it  has an abuse potential comparable to ketamine, indicating a risk of dependency.

• Severe Outcomes: There have been reports linking this to serious incidents, including self-mutilation and fatalities.

Legal Status

The legality of it varies by country:

• Illegal: Countries like Italy, Japan, Latvia, Singapore, Sweden, and Switzerland have banned it due to its high abuse potential.

• Controlled: In the United Kingdom, It is classified as a Class B substance under the Misuse of Drugs Act.

• Not Explicitly Controlled: In the United States, it is not specifically scheduled but could be subject to regulation under the Federal Analogue Act.

Conclusion

It is a synthetic drug with effects similar to ketamine, including dissociation and hallucinations. Its use carries significant risks, such as neurological and cardiovascular issues, and potential for addiction. The legal status of this varies globally, with many countries imposing strict controls due to health concerns. Individuals are advised to be aware of these risks and legal implications.